August 6, 2026

2026

Pulkit Samrat reveals marriage to Kriti Kharbanda transformed his life, ‘Wife makes you wise’

Pulkit Samrat reveals marriage to Kriti Kharbanda transformed his life, ‘Wife makes you wise’

Vamsikrishna02 mins mins

Pulkit Samrat cherishes post-marriage peace with Kriti Kharbanda, married March 15, 2024, in Gurugram. He credits love and therapy for wisdom and growth, gushing, “Wife makes you wise.” Upcoming in Glory, Rahu Ketu, and a Saif Ali Khan project, he radiates happiness. Pulkit Samrat’s acting journey and effortless style have long resonated with fans. Now…

Read More
Netflix deal: Paramount Skydance sues Warner Bros Discovery; seeks disclosure on .7 billion deal

Netflix deal: Paramount Skydance sues Warner Bros Discovery; seeks disclosure on $82.7 billion deal

Vamsikrishna03 mins mins

Paramount Skydance on Monday sued Warner Bros Discovery seeking greater disclosure on its proposed $82.7 billion deal with Netflix, escalating a high-stakes battle for control of one of Hollywood’s most storied media groups.The David Ellison-led company also said it plans to nominate directors to the Warner Bros Discovery board and prepare a proxy contest, marking…

Read More
“Best jumper in the tribe”: IShowSpeed earns rare title following viral jumping challenge in Kenya

“Best jumper in the tribe”: IShowSpeed earns rare title following viral jumping challenge in Kenya

Vamsikrishna02 mins mins

IShowSpeed (via Getty Images) IShowSpeed’s Africa streams have been a blast for fans as the popular streamer explored and visited various places across the continent. His entertaining attitude and vibrant energy charmed locals everywhere, who welcomed him with love and support wherever he went. His stints in Angola, Mozambique, Zimbabwe, and Botswana saw Speed embracing…

Read More
Education must be free from political considerations, says Delhi Minister Sood | India News

Education must be free from political considerations, says Delhi Minister Sood | India News

Vamsikrishna02 mins mins

NEW DELHI: Governance in the education sector must move beyond political interests to focus strictly on policy-driven structural reforms, Delhi Minister Ashish Sood said on Monday. He emphasised that the Delhi government is prioritising the long-term health of the academic system over short-term considerations. Speaking at a scholarship distribution ceremony for state university students at…

Read More
Trump’s new attack on US Federal Reserve revives ‘Sell America’ trade – why stock market strategists are worried about deeper selloff

Trump’s new attack on US Federal Reserve revives ‘Sell America’ trade – why stock market strategists are worried about deeper selloff

Vamsikrishna05 mins mins

Pressure linked to the ‘Sell America’ narrative is unlikely to fade. (AI image) US President Donald Trump’s fresh attack on the Federal Reserve seems to have revived the ‘Sell America’ sentiment in the stock market and strategists and market experts are warning that the selloff may deepen over time if the tiff between the government…

Read More
Vir Das calls Shah Rukh Khan’s ‘Happy New Year’ a ‘faltu’ film, Farah Khan reacts: ‘My film Happy Patel..’

Vir Das calls Shah Rukh Khan’s ‘Happy New Year’ a ‘faltu’ film, Farah Khan reacts: ‘My film Happy Patel..’

Vamsikrishna03 mins mins

As Vir Das gears up for his directorial debut with Aamir Khan Productions’ upcoming film ‘Happy Patel: Khatarnak Jasoos’, the actor-filmmaker recently appeared on Farah Khan’s cooking show with her cook Dilip. The filmmaker-choreographer dropped by Vir’s home as part of a shoot for her YouTube channel. During the interaction, Vir spoke candidly about his…

Read More
91-year-old woman scammed of more than K in Melbourne; cops release suspects’ photo, refer to them as of ‘Middle-Eastern appearance’

91-year-old woman scammed of more than $10K in Melbourne; cops release suspects’ photo, refer to them as of ‘Middle-Eastern appearance’

Vamsikrishna02 mins mins

The Victoria Police released photos and details of three suspects who scammed a 91-year-old woman of more than $10K in Melbourne’s east last year. Cops said these three men are believed to be of Mediterranean/Middle Eastern appearance. The elderly woman was contacted by one of them on March 3, 2025. The man told her he…

Read More
NEW DELHI: Demanding a thorough investigation into “betrayal of youth”, Congress on Monday claimed that the CAG has exposed a “massive scam” in the Pradhan Mantri Kaushal Vikas Yojana (PMKVY) which runs into thousands of crores with alleged fake beneficiaries and absentee trainers.Congress leader and former IAS officer Kannan Gopinathan said the recent CAG report on PMKVY from 2015 to 2022 found that the govt distributed Rs 10,000 crore in the seven years, but 94.5% of beneficiaries’ bank accounts turned out to be fake, 96% had fake mobile numbers, and 97% had fraud assessor details. He said information about 61 lakh trainers under the scheme was incomplete.Interestingly, Gopinathan said that the CAG found that one crore persons who completed the training under the scheme had the same email and mobile phone numbers.Quoting the CAG report, he said the audit, which examined PMKVY 2.0 and PMKVY 3.0, including short-term training, recognition of prior learning, and special projects — revealed weak oversight, widespread data manipulation, financial mismanagement, and violations of basic eligibility norms.According to Gopinathan, an analysis of nearly 60.7 lakh candidates in roles requiring education above Class 9 showed that education data of around 6.8 lakh candidates was missing, while nearly 8.1 lakh candidates did not meet minimum educational criteria. Out of a little over 1.2 lakh candidates certified for roles requiring prior technical education, a high 85.4% had only basic literacy or general education.End of ArticleFollow Us On Social MediaVideos“Deeply Impressed,” CEOs Share Takeaways After Meeting PM Modi | VideoFrom Defence To AI: PM Modi Urges German CEOs To Make India Their Global Manufacturing Base’Real Friends Always…’: Trump’s New Envoy Sergio Gor Pledges To Reset India-US TiesNot Trade Or Defence: Why Four-Year Old Baby Ariha Shah Became Key Topic In Modi–Germany TalksAAP’s Raghav Chadha Turns Blinkit Delivery Agent for a Day Amid Gig Workers’ Row’Will Come to Mumbai, Try Cutting My Legs: Annamalai Hits Back at Raj ThackerayIndia Tests Indigenous Fire And Forget Anti-Tank Missile With Top Attack Strike On Moving TargetsShaksgam Valley Row Deepens As China Rejects India’s Claim And Defends CPEC Infra Project With PakIndia To Join Pax Silica As US Signals New Tech Trust Despite Trade Tensions And Tariff DisputesGerman Chancellor Merz Hails India-Germany Ties, Pushes For ‘Economically Meaningful’ India-EU FTA123PhotostoriesHow to make Halwai Style Aloo Sabji at homeFrom mindful portions to intermittent fasting: When Taarak Mehta Ka Ooltah Chashmah’s Munmun Dutta gave a peek into her disciplined diet and daily routineTimothée Chalamet to Jacob Elordi: The Men of the 2026 Golden Globes who delivered a masterclass in modern tailoringThalapathy Vijay’s ‘Jana Nayagan’ delayed: 8 must-watch OTT hits to streamTamil Nadu Assembly Elections 2026: Alliances, numbers and the battle for 234 seats5 jungle survival tips Bear Grylls swears by, and how they apply beyond the wildChef Sanjeev Kapoor shares 5 crunchy snack recipes to enjoy with chai during winter `Best horror dramas on Apple TV: ‘The Enfield Poltergeist’, ‘Servant’ and moreFrom Zubeen Garg death to ‘vote chori’: Key political issues in 2026 Assam Assembly polls10 poorest countries in the world123Hot PicksISRO PSLV-C62 missionTrump tariffsGold rate todayBengaluru newsCigarette price hikePublic holidays January 2026Bank Holidays JanuaryTop TrendingStephen Curry BrotherLebron JamesMatthew and Brady Tkachuks Combined Net WorthVanessa BryantBengaluru Girl RapeConnor McDavidISRO LaunchGeorge Valera Net WorthNandani SharmaDarius Slay

NEW DELHI: Demanding a thorough investigation into “betrayal of youth”, Congress on Monday claimed that the CAG has exposed a “massive scam” in the Pradhan Mantri Kaushal Vikas Yojana (PMKVY) which runs into thousands of crores with alleged fake beneficiaries and absentee trainers.Congress leader and former IAS officer Kannan Gopinathan said the recent CAG report on PMKVY from 2015 to 2022 found that the govt distributed Rs 10,000 crore in the seven years, but 94.5% of beneficiaries’ bank accounts turned out to be fake, 96% had fake mobile numbers, and 97% had fraud assessor details. He said information about 61 lakh trainers under the scheme was incomplete.Interestingly, Gopinathan said that the CAG found that one crore persons who completed the training under the scheme had the same email and mobile phone numbers.Quoting the CAG report, he said the audit, which examined PMKVY 2.0 and PMKVY 3.0, including short-term training, recognition of prior learning, and special projects — revealed weak oversight, widespread data manipulation, financial mismanagement, and violations of basic eligibility norms.According to Gopinathan, an analysis of nearly 60.7 lakh candidates in roles requiring education above Class 9 showed that education data of around 6.8 lakh candidates was missing, while nearly 8.1 lakh candidates did not meet minimum educational criteria. Out of a little over 1.2 lakh candidates certified for roles requiring prior technical education, a high 85.4% had only basic literacy or general education.End of ArticleFollow Us On Social MediaVideos“Deeply Impressed,” CEOs Share Takeaways After Meeting PM Modi | VideoFrom Defence To AI: PM Modi Urges German CEOs To Make India Their Global Manufacturing Base’Real Friends Always…’: Trump’s New Envoy Sergio Gor Pledges To Reset India-US TiesNot Trade Or Defence: Why Four-Year Old Baby Ariha Shah Became Key Topic In Modi–Germany TalksAAP’s Raghav Chadha Turns Blinkit Delivery Agent for a Day Amid Gig Workers’ Row’Will Come to Mumbai, Try Cutting My Legs: Annamalai Hits Back at Raj ThackerayIndia Tests Indigenous Fire And Forget Anti-Tank Missile With Top Attack Strike On Moving TargetsShaksgam Valley Row Deepens As China Rejects India’s Claim And Defends CPEC Infra Project With PakIndia To Join Pax Silica As US Signals New Tech Trust Despite Trade Tensions And Tariff DisputesGerman Chancellor Merz Hails India-Germany Ties, Pushes For ‘Economically Meaningful’ India-EU FTA123PhotostoriesHow to make Halwai Style Aloo Sabji at homeFrom mindful portions to intermittent fasting: When Taarak Mehta Ka Ooltah Chashmah’s Munmun Dutta gave a peek into her disciplined diet and daily routineTimothée Chalamet to Jacob Elordi: The Men of the 2026 Golden Globes who delivered a masterclass in modern tailoringThalapathy Vijay’s ‘Jana Nayagan’ delayed: 8 must-watch OTT hits to streamTamil Nadu Assembly Elections 2026: Alliances, numbers and the battle for 234 seats5 jungle survival tips Bear Grylls swears by, and how they apply beyond the wildChef Sanjeev Kapoor shares 5 crunchy snack recipes to enjoy with chai during winter `Best horror dramas on Apple TV: ‘The Enfield Poltergeist’, ‘Servant’ and moreFrom Zubeen Garg death to ‘vote chori’: Key political issues in 2026 Assam Assembly polls10 poorest countries in the world123Hot PicksISRO PSLV-C62 missionTrump tariffsGold rate todayBengaluru newsCigarette price hikePublic holidays January 2026Bank Holidays JanuaryTop TrendingStephen Curry BrotherLebron JamesMatthew and Brady Tkachuks Combined Net WorthVanessa BryantBengaluru Girl RapeConnor McDavidISRO LaunchGeorge Valera Net WorthNandani SharmaDarius Slay

Vamsikrishna02 mins mins

NEW DELHI: Demanding a thorough investigation into “betrayal of youth”, Congress on Monday claimed that the CAG has exposed a “massive scam” in the Pradhan Mantri Kaushal Vikas Yojana (PMKVY) which runs into thousands of crores with alleged fake beneficiaries and absentee trainers.Congress leader and former IAS officer Kannan Gopinathan said the recent CAG report…

Read More
Fed showdown: Donald Trump’s legal move against Jerome Powell sharpens rate-cut battle; raises questions over central bank independence

Fed showdown: Donald Trump’s legal move against Jerome Powell sharpens rate-cut battle; raises questions over central bank independence

Vamsikrishna04 mins mins

The US Justice Department’s threat to criminally indict Federal Reserve Chair Jerome Powell has triggered a fresh confrontation between the White House and the central bank, intensifying concerns over the Fed’s independence and the direction of US monetary policy.The subpoenas, served on Friday, relate to Powell’s June testimony on the $2.5 billion renovation of Federal…

Read More
Farah Khan reveals Aamir Khan chopped Vir Das’ Jaa Chudail song from Delhi Belly because he was ‘jealous’; ‘Mujhko bola gaya ki ek pacing issue tha’

Farah Khan reveals Aamir Khan chopped Vir Das’ Jaa Chudail song from Delhi Belly because he was ‘jealous’; ‘Mujhko bola gaya ki ek pacing issue tha’

Vamsikrishna02 mins mins

Actor and stand-up comedian Vir Das was the latest guest on Farah Khan’s vlog, where the choreographer-director visited his home for a candid chat ahead of the release of his upcoming film Happy Patel. What stood out from the conversation, however, was Farah’s hilarious revelation about Delhi Belly and why Vir’s popular song Jaa Chudail…

Read More
Vande Bharat sleeper fares out! Indian Railways to launch new train on Howrah-Guwahati route; check ticket price & top features

Vande Bharat sleeper fares out! Indian Railways to launch new train on Howrah-Guwahati route; check ticket price & top features

Vamsikrishna04 mins mins

Vande Bharat sleeper launch soon! Indian Railways is all set to launch its first Vande Bharat sleeper this week, with PM Narendra Modi expected to flag off the new train on January 117 between Howrah and Kamakhya (Guwahati). Ahead of the launch, Indian Railways has announced the fare structure and ticket prices for the Vande…

Read More
NEW DELHI: In a significant ‘public interest’ move, the Delhi High Court has allowed Zydus Lifesciences to manufacture and sell a biosimilar of Bristol Myers Squibb’s blockbuster cancer therapy, Nivolumab. Priced around 70% less than the patented therapy, the Zydus biosimilar is expected to improve patient access and affordability significantly.A division bench of Justices C Hari Shankar and Om Prakash Shukla on Monday set aside an earlier single-judge order that had blocked the entry of Zydus’ version. The court observed that “where the product in question is a life-saving drug, the court has to err in favour of public interest,” adding that the innovator’s interests could be protected through alternative safeguards.Last year, a single bench had stopped Zydus from marketing the biosimilar, ZRC 3276, an anticancer drug which is essential for treatment of a wide variety of life-threatening cancers, on the ground that the product infringes the innovator’s patent.The order comes four months ahead of the expiry of BMS’ patent on Nivolumab, marketed as Opdiva, on May 2, 2026. “Given the nature of the product, and applying the principle of balance of convenience, too, the interests of justice would require the appellant to be bound down to maintain accounts of the realizations from the sale of its product till the expiry of the suit patent, rather than depriving the ailing public of access to the product’’, the order, accessed by TOI, said.The order has directed Zydus to maintain accounts of the biosimilar sales till the patent expires.Noting that the courts have to walk a tightrope between public interest and intellectual property, they said in the order: “Courts have to be acutely conscious of their duties in such matters. The tightrope is shaky, and walking it is not always an enviable enterprise. Our oath of office, however, obligates us to do so and, while doing so, we have to bear in mind our duty to the teeming citizenry of this country who may be in dire need of the therapy, the release of which a plaintiff seeks to injunct”.Further, it added “There is, at the same time, also a pre-eminent element of public interest in ensuring protection of valuable patents, which should not be forgotten. If Courts are to swing to the other extreme, and openly allow circulation, in the market, of drugs which infringe valuable pharmaceutical patents, the incentive to invent would be altogether lost, which might result in ebbing the stream at the source. There would be no incentive to expend valuable time, energy and often cripplingly huge financial resources in inventing a new and more efficacious drug, if one is not ensured of patent protection as available in law”.About the AuthorRupali MukherjeeA business journalist with around two decades of experience tracking key consumer-focussed sectors like consumer durables, retail, consumer goods, aviation, automobiles and advertising, as well as economic ministries of the Union government. Now, writes primarily on pharmaceuticals and healthcare, and on issues of consumer interest. Besides also looks at trends that are shaping consumer behaviour and the broad consumer landscape. \nYou can follow Rupali on Twitter@Rupalijee.Read MoreEnd of ArticleFollow Us On Social MediaVideosFrom Defence To AI: PM Modi Urges German CEOs To Make India Their Global Manufacturing Base’Real Friends Always…’: Trump’s New Envoy Sergio Gor Pledges To Reset India-US TiesNot Trade Or Defence: Why Four-Year Old Baby Ariha Shah Became Key Topic In Modi–Germany TalksAAP’s Raghav Chadha Turns Blinkit Delivery Agent for a Day Amid Gig Workers’ Row’Will Come to Mumbai, Try Cutting My Legs: Annamalai Hits Back at Raj ThackerayIndia Tests Indigenous Fire And Forget Anti-Tank Missile With Top Attack Strike On Moving TargetsShaksgam Valley Row Deepens As China Rejects India’s Claim And Defends CPEC Infra Project With PakIndia To Join Pax Silica As US Signals New Tech Trust Despite Trade Tensions And Tariff DisputesGerman Chancellor Merz Hails India-Germany Ties, Pushes For ‘Economically Meaningful’ India-EU FTA‘This Is Not India’: Protesters Disrupt Sikh Nagar Kirtan Again In New Zealand With Haka Display123PhotostoriesHow to make Halwai Style Aloo Sabji at homeFrom mindful portions to intermittent fasting: When Taarak Mehta Ka Ooltah Chashmah’s Munmun Dutta gave a peek into her disciplined diet and daily routineTimothée Chalamet to Jacob Elordi: The Men of the 2026 Golden Globes who delivered a masterclass in modern tailoringThalapathy Vijay’s ‘Jana Nayagan’ delayed: 8 must-watch OTT hits to streamTamil Nadu Assembly Elections 2026: Alliances, numbers and the battle for 234 seats5 jungle survival tips Bear Grylls swears by, and how they apply beyond the wildChef Sanjeev Kapoor shares 5 crunchy snack recipes to enjoy with chai during winter `Best horror dramas on Apple TV: ‘The Enfield Poltergeist’, ‘Servant’ and moreFrom Zubeen Garg death to ‘vote chori’: Key political issues in 2026 Assam Assembly polls10 poorest countries in the world123Hot PicksISRO PSLV-C62 missionTrump tariffsGold rate todayBengaluru newsCigarette price hikePublic holidays January 2026Bank Holidays JanuaryTop TrendingStephen Curry BrotherLebron JamesMatthew and Brady Tkachuks Combined Net WorthVanessa BryantBengaluru Girl RapeConnor McDavidISRO LaunchGeorge Valera Net WorthNandani SharmaDarius Slay

NEW DELHI: In a significant ‘public interest’ move, the Delhi High Court has allowed Zydus Lifesciences to manufacture and sell a biosimilar of Bristol Myers Squibb’s blockbuster cancer therapy, Nivolumab. Priced around 70% less than the patented therapy, the Zydus biosimilar is expected to improve patient access and affordability significantly.A division bench of Justices C Hari Shankar and Om Prakash Shukla on Monday set aside an earlier single-judge order that had blocked the entry of Zydus’ version. The court observed that “where the product in question is a life-saving drug, the court has to err in favour of public interest,” adding that the innovator’s interests could be protected through alternative safeguards.Last year, a single bench had stopped Zydus from marketing the biosimilar, ZRC 3276, an anticancer drug which is essential for treatment of a wide variety of life-threatening cancers, on the ground that the product infringes the innovator’s patent.The order comes four months ahead of the expiry of BMS’ patent on Nivolumab, marketed as Opdiva, on May 2, 2026. “Given the nature of the product, and applying the principle of balance of convenience, too, the interests of justice would require the appellant to be bound down to maintain accounts of the realizations from the sale of its product till the expiry of the suit patent, rather than depriving the ailing public of access to the product’’, the order, accessed by TOI, said.The order has directed Zydus to maintain accounts of the biosimilar sales till the patent expires.Noting that the courts have to walk a tightrope between public interest and intellectual property, they said in the order: “Courts have to be acutely conscious of their duties in such matters. The tightrope is shaky, and walking it is not always an enviable enterprise. Our oath of office, however, obligates us to do so and, while doing so, we have to bear in mind our duty to the teeming citizenry of this country who may be in dire need of the therapy, the release of which a plaintiff seeks to injunct”.Further, it added “There is, at the same time, also a pre-eminent element of public interest in ensuring protection of valuable patents, which should not be forgotten. If Courts are to swing to the other extreme, and openly allow circulation, in the market, of drugs which infringe valuable pharmaceutical patents, the incentive to invent would be altogether lost, which might result in ebbing the stream at the source. There would be no incentive to expend valuable time, energy and often cripplingly huge financial resources in inventing a new and more efficacious drug, if one is not ensured of patent protection as available in law”.About the AuthorRupali MukherjeeA business journalist with around two decades of experience tracking key consumer-focussed sectors like consumer durables, retail, consumer goods, aviation, automobiles and advertising, as well as economic ministries of the Union government. Now, writes primarily on pharmaceuticals and healthcare, and on issues of consumer interest. Besides also looks at trends that are shaping consumer behaviour and the broad consumer landscape. \nYou can follow Rupali on Twitter@Rupalijee.Read MoreEnd of ArticleFollow Us On Social MediaVideosFrom Defence To AI: PM Modi Urges German CEOs To Make India Their Global Manufacturing Base’Real Friends Always…’: Trump’s New Envoy Sergio Gor Pledges To Reset India-US TiesNot Trade Or Defence: Why Four-Year Old Baby Ariha Shah Became Key Topic In Modi–Germany TalksAAP’s Raghav Chadha Turns Blinkit Delivery Agent for a Day Amid Gig Workers’ Row’Will Come to Mumbai, Try Cutting My Legs: Annamalai Hits Back at Raj ThackerayIndia Tests Indigenous Fire And Forget Anti-Tank Missile With Top Attack Strike On Moving TargetsShaksgam Valley Row Deepens As China Rejects India’s Claim And Defends CPEC Infra Project With PakIndia To Join Pax Silica As US Signals New Tech Trust Despite Trade Tensions And Tariff DisputesGerman Chancellor Merz Hails India-Germany Ties, Pushes For ‘Economically Meaningful’ India-EU FTA‘This Is Not India’: Protesters Disrupt Sikh Nagar Kirtan Again In New Zealand With Haka Display123PhotostoriesHow to make Halwai Style Aloo Sabji at homeFrom mindful portions to intermittent fasting: When Taarak Mehta Ka Ooltah Chashmah’s Munmun Dutta gave a peek into her disciplined diet and daily routineTimothée Chalamet to Jacob Elordi: The Men of the 2026 Golden Globes who delivered a masterclass in modern tailoringThalapathy Vijay’s ‘Jana Nayagan’ delayed: 8 must-watch OTT hits to streamTamil Nadu Assembly Elections 2026: Alliances, numbers and the battle for 234 seats5 jungle survival tips Bear Grylls swears by, and how they apply beyond the wildChef Sanjeev Kapoor shares 5 crunchy snack recipes to enjoy with chai during winter `Best horror dramas on Apple TV: ‘The Enfield Poltergeist’, ‘Servant’ and moreFrom Zubeen Garg death to ‘vote chori’: Key political issues in 2026 Assam Assembly polls10 poorest countries in the world123Hot PicksISRO PSLV-C62 missionTrump tariffsGold rate todayBengaluru newsCigarette price hikePublic holidays January 2026Bank Holidays JanuaryTop TrendingStephen Curry BrotherLebron JamesMatthew and Brady Tkachuks Combined Net WorthVanessa BryantBengaluru Girl RapeConnor McDavidISRO LaunchGeorge Valera Net WorthNandani SharmaDarius Slay

Vamsikrishna03 mins mins

NEW DELHI: In a significant ‘public interest’ move, the Delhi High Court has allowed Zydus Lifesciences to manufacture and sell a biosimilar of Bristol Myers Squibb’s blockbuster cancer therapy, Nivolumab. Priced around 70% less than the patented therapy, the Zydus biosimilar is expected to improve patient access and affordability significantly.A division bench of Justices C…

Read More
US markets today: Wall Street drifts lower as White House–Fed feud unnerves investors; dollar weakens, gold gains

US markets today: Wall Street drifts lower as White House–Fed feud unnerves investors; dollar weakens, gold gains

Vamsikrishna03 mins mins

US stocks edged lower on Monday as investors showed signs of unease over a sharp escalation in tensions between the White House and the Federal Reserve, two Washington institutions whose independence markets have traditionally taken for granted. The S&P 500 slipped 0.3 per cent from its record high, while assets that typically benefit during periods…

Read More
India, Germany ink higher education roadmap; PM Modi pitches campus expansion: Here’s what’s in it for students

India, Germany ink higher education roadmap; PM Modi pitches campus expansion: Here’s what’s in it for students

Vamsikrishna03 mins mins

India and Germany have adopted a higher education roadmap that places universities and student mobility at the centre of a broader bilateral push, with Prime Minister Narendra Modi inviting foreign institutions to establish campuses in India during German Chancellor Friedrich Merz’s official visit in Gandhinagar.Addressing a joint press conference, Modi said the roadmap would give…

Read More